Deciphering The Complexity Of Therapeutic Biologics: A Dedicated Characterization Strategy For Understanding Critical Quality Attributes

Therapeutic biologics continue to grow in complexity, making it increasingly important to deeply understand the molecular features that influence how these therapies perform. Critical quality attributes (CQAs) — the structural and functional characteristics that shape safety, efficacy, and long‑term stability — sit at the center of this challenge. As biologics become more intricate, especially across bispecific and multispecific antibody formats, a clear strategy for identifying and characterizing these attributes is essential.

This session explores a practical, modality‑agnostic approach to decoding CQAs using an integrated analytical toolbox. By combining mass spectrometry, chromatographic techniques, and biophysical analysis, scientists can build a clearer picture of the heterogeneity and subtle molecular variations that impact product quality. Attendees will gain insights into how different CQA categories are evaluated, why these categories matter, and how to apply these characterization principles to emerging biologic formats.

Real-world case studies will illustrate how comprehensive CQA assessment supports development decisions and strengthens quality control. Access the full webinar to learn how to apply these strategies to your own biologic programs.